{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:56:15Z","timestamp":1788900975076,"version":"build-2803163510"},"reference-count":40,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00567"],"award-info":[{"award-number":["PI15\/00567"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Vascular aging (arterial stiffness [AS]) is an inflammation-linked process that predicts macro- and microvascular complications in adults with type 1 diabetes (T1D). We evaluated the utility of measuring the inflammation-linked N-glycans GlycA and GlycB to assess vascular aging in adults with T1D.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Eighty-four adults with T1D (&amp;gt;10-year duration without cardiovascular events) and 68 healthy control subjects were evaluated for clinical characteristics (including microvascular complications in patients with T1D), aortic pulse wave velocity (aPWV) (surrogate measure of AS), and serum GlycA and GlycB (peak area [concentration] and height\/width [H\/W] ratio) using 1H-nuclear magnetic resonance spectroscopy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Patients with T1D had higher median (interquartile range) values than healthy control subjects for (P &amp;lt; 0.001 for all comparisons) aPWV 7.9 (6.9\u20139.1) vs. 6.1 (5.5\u20136.7) m\/s, GlycA 850.4 (781.3\u2013916.1) vs. 652.4 (581.5\u2013727.1) \u03bcmoL; GlycB 386.1 (353.2\u2013426.3) vs. 310.0 (280.5\u2013331.9) \u03bcmol\/L), H\/W ratio of GlycA 16.5 (14.9\u201318.1) vs. 15.0 (13.7\u201316.7), and H\/W ratio of GlycB 5.0 (4.6\u20135.5) vs. 4.0 (3.4\u20134.3). Moreover, aPWV correlated (P &amp;lt; 0.001 for all correlations) with GlycA (r = 0.550) and GlycB (r = 0.423) concentrations and with H\/W ratios of GlycA (r = 0.453) and GlycB (r = 0.510). Adjusting for potential confounders, GlycA concentration (\u03b2 = 0.212, P &amp;lt; 0.001) and the H\/W ratios of GlycA (\u03b2 = 0.150, P = 0.009) and GlycB (\u03b2 = 0.155, P = 0.011) remained independently associated with aPWV. C-statistics for detecting individuals with aPWV &amp;gt;10 m\/s were 0.866 (95% CI 0.794\u20130.937) for GlycA levels and 0.862 (0.780\u20130.943) for H\/W ratio of GlycB.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Measurement of serum GlycA and GlycB may have utility in assessing vascular aging in adults with T1D of &amp;gt;10-year duration and no previous cardiovascular events.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc22-0331","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T11:57:17Z","timestamp":1660910237000},"page":"2430-2438","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":8,"title":["Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes"],"prefix":"10.2337","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3237-6366","authenticated-orcid":false,"given":"Gemma","family":"Llaurad\u00f3","sequence":"first","affiliation":[{"name":"1Department of Endocrinology and Nutrition, Hospital del Mar, Institut Hospital del Mar d\u2019Investigacions M\u00e8diques (IMIM), Barcelona, Spain"},{"name":"2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Amig\u00f3","sequence":"additional","affiliation":[{"name":"2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain"},{"name":"3Biosfer Teslab SL, Reus, Spain"},{"name":"4Department of Basic Medical Sciences, Rovira i Virgili University, Tarragona-Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Fuertes-Mart\u00edn","sequence":"additional","affiliation":[{"name":"2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain"},{"name":"3Biosfer Teslab SL, Reus, Spain"},{"name":"5Department of Electronics, Electrical and Automatic Engineering Platform, Pere Virgili Health Research Institute (IISPV), Rovira i Virgili University, Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Romero","sequence":"additional","affiliation":[{"name":"6Department of Endocrinology and Nutrition, Parc Taul\u00ed University Hospital, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT, Universitat Aut\u00f2noma de Barcelona, Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Cano","sequence":"additional","affiliation":[{"name":"6Department of Endocrinology and Nutrition, Parc Taul\u00ed University Hospital, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT, Universitat Aut\u00f2noma de Barcelona, Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Albert","sequence":"additional","affiliation":[{"name":"6Department of Endocrinology and Nutrition, Parc Taul\u00ed University Hospital, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT, Universitat Aut\u00f2noma de Barcelona, Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Gim\u00e9nez-Palop","sequence":"additional","affiliation":[{"name":"6Department of Endocrinology and Nutrition, Parc Taul\u00ed University Hospital, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT, Universitat Aut\u00f2noma de Barcelona, Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Berlanga","sequence":"additional","affiliation":[{"name":"7Clinical Laboratory, Biochemistry Department, UDIAT, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT, Universitat Aut\u00f2noma de Barcelona, Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2906-3788","authenticated-orcid":false,"given":"Sonia","family":"Fern\u00e1ndez-Veledo","sequence":"additional","affiliation":[{"name":"2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain"},{"name":"8Endocrinology and Nutrition Service, Joan XXIII University Hospital, Pere Virgili Health Research Institute (IISPV), Rovira i Virgili University, Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Correig","sequence":"additional","affiliation":[{"name":"2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain"},{"name":"5Department of Electronics, Electrical and Automatic Engineering Platform, Pere Virgili Health Research Institute (IISPV), Rovira i Virgili University, Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6994-6115","authenticated-orcid":false,"given":"Joan","family":"Vendrell","sequence":"additional","affiliation":[{"name":"2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain"},{"name":"8Endocrinology and Nutrition Service, Joan XXIII University Hospital, Pere Virgili Health Research Institute (IISPV), Rovira i Virgili University, Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7409-8720","authenticated-orcid":false,"given":"Jos\u00e9-Miguel","family":"Gonz\u00e1lez-Clemente","sequence":"additional","affiliation":[{"name":"2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain"},{"name":"6Department of Endocrinology and Nutrition, Parc Taul\u00ed University Hospital, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT, Universitat Aut\u00f2noma de Barcelona, Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"2022092319000941300_B1","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/HYPERTENSIONAHA.120.14971","article-title":"Early and supernormal vascular aging: clinical characteristics and association with incident cardiovascular events","volume":"76","author":"Bruno","year":"2020","journal-title":"Hypertension"},{"key":"2022092319000941300_B2","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/HYPERTENSIONAHA.120.16128","article-title":"\u201cMan is as old as his arteries\u201d taken literally: in search of the best metric","volume":"76","author":"Weber","year":"2020","journal-title":"Hypertension"},{"key":"2022092319000941300_B3","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jacc.2019.07.012","article-title":"Large-artery stiffness in health and disease: JACC state-of-the-art review","volume":"74","author":"Chirinos","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022092319000941300_B4","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2022092319000941300_B5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2013.09.063","article-title":"Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects","volume":"63","author":"Ben-Shlomo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022092319000941300_B6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2014.16425","article-title":"Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010","volume":"313","author":"Livingstone","year":"2015","journal-title":"JAMA"},{"key":"2022092319000941300_B7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/dc12-0850","article-title":"Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes","volume":"36","author":"Theilade","year":"2013","journal-title":"Diabetes Care"},{"key":"2022092319000941300_B8","doi-asserted-by":"crossref","first-page":"e017165","DOI":"10.1161\/JAHA.120.017165","article-title":"Carotid-femoral pulse wave velocity as a risk marker for development of complications in type 1 diabetes mellitus","volume":"9","author":"Tougaard","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2022092319000941300_B9","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.3390\/jcm10163616","article-title":"Arterial stiffness in type 1 diabetes: the case for the arterial wall itself as a target organ","volume":"10","author":"Gonz\u00e1lez-Clemente","year":"2021","journal-title":"J Clin Med"},{"key":"2022092319000941300_B10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.117.07802","article-title":"Oxidative stress, inflammation, and vascular aging in hypertension","volume":"70","author":"Guzik","year":"2017","journal-title":"Hypertension"},{"issue":"Pt B","key":"2022092319000941300_B11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mad.2016.12.008","article-title":"Inflammaging and human longevity in the omics era","volume":"165","author":"Monti","year":"2017","journal-title":"Mech Ageing Dev"},{"key":"2022092319000941300_B12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/dc11-1475","article-title":"Arterial stiffness is increased in patients with type 1 diabetes without cardiovascular disease: a potential role of low-grade inflammation","volume":"35","author":"Llaurad\u00f3","year":"2012","journal-title":"Diabetes Care"},{"key":"2022092319000941300_B13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/jcm9020354","article-title":"Human serum\/plasma glycoprotein analysis by 1H-NMR, an emerging method of inflammatory assessment","volume":"9","author":"Fuertes-Mart\u00edn","year":"2020","journal-title":"J Clin Med"},{"key":"2022092319000941300_B14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2018.10.029","article-title":"Higher plasma GlycA, a novel pro-inflammatory glycoprotein biomarker, is associated with reduced life expectancy: the PREVEND study","volume":"488","author":"Gruppen","year":"2019","journal-title":"Clin Chim Acta"},{"key":"2022092319000941300_B15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2022092319000941300_B16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1249\/01.MSS.0000117161.66394.07","article-title":"Reliability and validity of the International Physical Activity Questionnaire (IPAQ)","volume":"36","author":"Hallal","year":"2004","journal-title":"Med Sci Sports Exerc"},{"key":"2022092319000941300_B17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2022092319000941300_B18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","article-title":"Can clinical factors estimate insulin resistance in type 1 diabetes?","volume":"49","author":"Williams","year":"2000","journal-title":"Diabetes"},{"key":"2022092319000941300_B19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/dc06-1982","article-title":"Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: \u201cdouble diabetes\u201d in the Diabetes Control and Complications Trial","volume":"30","author":"Kilpatrick","year":"2007","journal-title":"Diabetes Care"},{"key":"2022092319000941300_B20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/eje.1.02016","article-title":"The tumour necrosis factor (TNF)-alpha system is activated in accordance with pulse pressure in normotensive subjects with type 1 diabetes mellitus","volume":"153","author":"Gonz\u00e1lez-Clemente","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2022092319000941300_B21","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.2337\/dc21-S011","article-title":"11. Microvascular complications and foot care: Standards of Medical Care in Diabetes-2021","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"key":"2022092319000941300_B22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/JOE-13-0407","article-title":"Advanced glycation end products are associated with arterial stiffness in type 1 diabetes","volume":"221","author":"Llaurad\u00f3","year":"2014","journal-title":"J Endocrinol"},{"key":"2022092319000941300_B23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"2022092319000941300_B24","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1021\/acs.jproteome.9b00528","article-title":"Glycoprotein A and B height-to-width ratios as obesity-independent novel biomarkers of low-grade chronic inflammation in women with polycystic ovary syndrome (PCOS)","volume":"18","author":"Fuertes-Mart\u00edn","year":"2019","journal-title":"J Proteome Res"},{"key":"2022092319000941300_B25","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications","volume":"27","author":"Laurent","year":"2006","journal-title":"Eur Heart J"},{"key":"2022092319000941300_B26","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.numecd.2021.03.021","article-title":"Quantification of glycoproteins by nuclear magnetic resonance associated with preclinical carotid atherosclerosis in patients with type 1 diabetes","volume":"31","author":"Ser\u00e9s-Noriega","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2022092319000941300_B27","doi-asserted-by":"crossref","first-page":"e001221","DOI":"10.1161\/JAHA.114.001221","article-title":"A novel protein glycan biomarker and future cardiovascular disease events","volume":"3","author":"Akinkuolie","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2022092319000941300_B28","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.115.308078","article-title":"Circulating N-linked glycoprotein acetyls and longitudinal mortality risk","volume":"118","author":"Lawler","year":"2016","journal-title":"Circ Res"},{"key":"2022092319000941300_B29","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1373\/clinchem.2016.255828","article-title":"Comparison of the predictive value of GlycA and other biomarkers of inflammation for total death, incident cardiovascular events, noncardiovascular and noncancer inflammatory-related events, and total cancer events","volume":"62","author":"Duprez","year":"2016","journal-title":"Clin Chem"},{"key":"2022092319000941300_B30","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/clc.23069","article-title":"Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker: the Multi-Ethnic Study of Atherosclerosis","volume":"41","author":"Benson","year":"2018","journal-title":"Clin Cardiol"},{"key":"2022092319000941300_B31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.atherosclerosis.2019.01.011","article-title":"The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: the Multi-Ethnic Study of Atherosclerosis","volume":"282","author":"Ezeigwe","year":"2019","journal-title":"Atherosclerosis"},{"key":"2022092319000941300_B32","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke","volume":"71","author":"Holmes","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022092319000941300_B33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HYPERTENSIONAHA.119.13255","article-title":"Retinal microvasculature in relation to central hemodynamics in a Flemish population","volume":"74","author":"Wei","year":"2019","journal-title":"Hypertension"},{"key":"2022092319000941300_B34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/HYPERTENSIONAHA.111.177469","article-title":"Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension","volume":"58","author":"Hashimoto","year":"2011","journal-title":"Hypertension"},{"key":"2022092319000941300_B35","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/CIRCULATIONAHA.118.032410","article-title":"Higher aortic stiffness is related to lower cerebral blood flow and preserved cerebrovascular reactivity in older adults","volume":"138","author":"Jefferson","year":"2018","journal-title":"Circulation"},{"key":"2022092319000941300_B36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood","volume":"317","author":"Dabelea","year":"2017","journal-title":"JAMA"},{"key":"2022092319000941300_B37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2022092319000941300_B38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tem.2020.01.015","article-title":"Dyslipidemia in type 1 diabetes: a masked danger","volume":"31","author":"Verg\u00e8s","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"2022092319000941300_B39","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3390\/jcm8111875","article-title":"Specific nuclear magnetic resonance lipoprotein subclass profiles and central arterial stiffness in type 1 diabetes mellitus: a case control study","volume":"8","author":"Llaurad\u00f3","year":"2019","journal-title":"J Clin Med"},{"key":"2022092319000941300_B40","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/10\/2430\/688691\/dc220331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/10\/2430\/688691\/dc220331.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T19:07:12Z","timestamp":1663960032000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/45\/10\/2430\/147461\/Measurement-of-Serum-N-Glycans-in-the-Assessment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,8,19]]},"published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc22-0331","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]}}}